Spain
· Delayed Price · Currency is EUR Facephi Biometria Statistics
Total Valuation
BME:FACE has a market cap or net worth of EUR 62.22 million. The enterprise value is 66.64 million.
| Market Cap | 62.22M |
| Enterprise Value | 66.64M |
Important Dates
The last earnings date was Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:FACE has 25.60 million shares outstanding.
| Current Share Class | 25.60M |
| Shares Outstanding | 25.60M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.67% |
| Owned by Institutions (%) | 16.82% |
| Float | 23.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 24.30 |
| PS Ratio | 1.86 |
| PB Ratio | 3.24 |
| P/TBV Ratio | 8.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.60 |
Enterprise Valuation
| EV / Earnings | -7.50 |
| EV / Sales | 1.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.08 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.55 |
Financial Efficiency
Return on equity (ROE) is -45.29% and return on invested capital (ROIC) is -13.88%.
| Return on Equity (ROE) | -45.29% |
| Return on Assets (ROA) | -9.07% |
| Return on Invested Capital (ROIC) | -13.88% |
| Return on Capital Employed (ROCE) | -30.53% |
| Revenue Per Employee | 143,605 |
| Profits Per Employee | -38,130 |
| Employee Count | 264 |
| Asset Turnover | 0.70 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.95% in the last 52 weeks. The beta is 1.07, so BME:FACE's price volatility has been similar to the market average.
| Beta (5Y) | 1.07 |
| 52-Week Price Change | +29.95% |
| 50-Day Moving Average | 2.35 |
| 200-Day Moving Average | 1.87 |
| Relative Strength Index (RSI) | 56.79 |
| Average Volume (20 Days) | 12,921 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:FACE had revenue of EUR 33.46 million and -8.88 million in losses.
| Revenue | 33.46M |
| Gross Profit | 28.68M |
| Operating Income | -6.92M |
| Pretax Income | -7.33M |
| Net Income | -8.88M |
| EBITDA | -6.27M |
| EBIT | -6.92M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 5.74 million in cash and 10.16 million in debt, giving a net cash position of -4.42 million or -0.17 per share.
| Cash & Cash Equivalents | 5.74M |
| Total Debt | 10.16M |
| Net Cash | -4.42M |
| Net Cash Per Share | -0.17 |
| Equity (Book Value) | 19.19M |
| Book Value Per Share | n/a |
| Working Capital | 2.05M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 85.71%, with operating and profit margins of -20.70% and -26.55%.
| Gross Margin | 85.71% |
| Operating Margin | -20.70% |
| Pretax Margin | -21.91% |
| Profit Margin | -26.55% |
| EBITDA Margin | -18.74% |
| EBIT Margin | -20.70% |
| FCF Margin | n/a |
Dividends & Yields
BME:FACE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -14.28% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:FACE has an Altman Z-Score of 0.82. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.82 |
| Piotroski F-Score | n/a |